Ana Paula Candiota was born in Brazil on October 30, 1971. She has dual citizenship, Spanish and Brazilian. She was granted short-term fellowships three times from Agencia Española de Cooperación Internacional (1997, 1998, and 1999). Since 2007, she has held a postdoctoral position in CIBER (Centro de Investigación Biomédica en Red), ascribed to GABRMN. She has coordinated preclinical studies and the supervision of PhD and master's degree students. She is also in charge of the scientific coordination of Unit 25, NMR: Biomedical Applications I, of the Singular Scientific Technological Infrastructures (ICTS) NANBIOSIS, CIBER-BBN/UAB. She is the author of forty-one Scopus-indexed publications and has an h-index of 13 (Researcher ID A-4531-2009; ORCID 0000-0002-1523-6505). Her main expertise is preclinical MRI/MRSI, especially in regard to brain tumors.
Research Keywords & Expertise
Brain Tumors
Immune System
Molecular Imaging
magnetic resonance
Preclinical models
Biomarker Discovery/de...
magnetic resonance spe...
Fingerprints
50%
magnetic resonance
24%
Brain Tumors
17%
magnetic resonance spectroscopy
11%
Preclinical models
10%
Immune System
6%
Molecular Imaging
Short Biography
Ana Paula Candiota was born in Brazil on October 30, 1971. She has dual citizenship, Spanish and Brazilian. She was granted short-term fellowships three times from Agencia Española de Cooperación Internacional (1997, 1998, and 1999). Since 2007, she has held a postdoctoral position in CIBER (Centro de Investigación Biomédica en Red), ascribed to GABRMN. She has coordinated preclinical studies and the supervision of PhD and master's degree students. She is also in charge of the scientific coordination of Unit 25, NMR: Biomedical Applications I, of the Singular Scientific Technological Infrastructures (ICTS) NANBIOSIS, CIBER-BBN/UAB. She is the author of forty-one Scopus-indexed publications and has an h-index of 13 (Researcher ID A-4531-2009; ORCID 0000-0002-1523-6505). Her main expertise is preclinical MRI/MRSI, especially in regard to brain tumors.